How will Covid-19/Coronavirus Affect my Alternative Investment Portfolio? Part 34: October 18

Updated: Feb 8

U.S. progress fighting second death wave continues to fizzle out; World round up: Spain may be turning the corner, while rest of Europe skids further out of control; State round up: virus surges further and faster across multiple U.S. regions as winter approaches; How the U.S. pandemic is fundamentally changing: more widespread and more rural; Georgia's bellwether economy finally shows slow improvement, but ominous clouds may loom on the horizon; No rest for the weary: economy takes yet another hit from more massive unemployment; Financial cliff update: one step forward and one step back; History suggests U.S.'s November election unlikely to change total real estate returns; The grueling health battles of Covid-19 "Long Haulers"; Study suggests Covid-19 might live for weeks in winter on cash, touchscreens, door handles and grab rails; Johnson & Johnson's vaccine trial halted for safety concerns as it becomes second adenovirus-based vaccine to go into "time-out"; Eli Lilly's Covid-19 antibody treatment becomes the third medicine halted due to safety concerns; Pfizer joins Moderna in targeting late November for Covid-19 vaccine emergency-use approval; Study finds first generation vaccines are "unlikely" to end the pandemic or get us to herd immunity; Update on my investment strategy.